| Product Code: ETC9678138 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Antimicrobial Resistance Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Thailand Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Thailand Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Thailand Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Thailand Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Thailand Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Thailand Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Thailand |
4.2.2 Growing awareness about the importance of antimicrobial resistance |
4.2.3 Government initiatives to address antimicrobial resistance |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas |
4.3.2 Lack of proper regulations and enforcement measures |
4.3.3 High cost associated with antimicrobial resistance treatments |
5 Thailand Antimicrobial Resistance Market Trends |
6 Thailand Antimicrobial Resistance Market, By Types |
6.1 Thailand Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Thailand Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Thailand Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Thailand Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Thailand Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Thailand Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Thailand Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Thailand Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Thailand Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Thailand Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Thailand Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Thailand Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Thailand Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Thailand Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Thailand Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Thailand Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Thailand Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Thailand Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Thailand Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Thailand Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Thailand Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Thailand Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Thailand Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Thailand Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Thailand Antimicrobial Resistance Market Export to Major Countries |
7.2 Thailand Antimicrobial Resistance Market Imports from Major Countries |
8 Thailand Antimicrobial Resistance Market Key Performance Indicators |
8.1 Number of reported cases of antimicrobial resistance in Thailand |
8.2 Percentage of healthcare facilities following antimicrobial stewardship programs |
8.3 Investment in research and development of new antimicrobial drugs |
8.4 Public awareness campaigns on antimicrobial resistance |
8.5 Rate of adoption of guidelines and policies related to antimicrobial resistance |
9 Thailand Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Thailand Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Thailand Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Thailand Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Thailand Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Thailand Antimicrobial Resistance Market - Competitive Landscape |
10.1 Thailand Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Thailand Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here